ArticleFrontiers in public health2025
Acceptance and impact of Nirsevimab and the RSVpreF vaccine following implementation in Austria.
Michaela Höck et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it